Naturally acquired human immune responses against Helicobacter pylori and implications for vaccine development

Gut

Volumn 45, Issue 3, 1999, Pages 465-474

  Zevering, Y ^a,b   Jacob, L ^a   Meyer, T F ^a  

^a Max Planck Institute for Molecular Genetics and Max Planck Unit for the Science of Pathogens   (Germany)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN PRESENTING CELL; BACTERIAL INFECTION; CELL DEGENERATION; CELL PROTECTION; EPITHELIUM CELL; HELICOBACTER PYLORI; HUMORAL IMMUNITY; IMMUNE RESPONSE; PRIORITY JOURNAL; REVIEW; VACCINE PRODUCTION;

EID: 0032798418     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.45.3.465     Document Type: Review

References (146)

1. 1 Wyle FA, Tarnawski A, Schulman D, et al. Evidence for gastric mucosal cell invasion by C. pylori: an ultrastructural study. J Clin Gastroenterol 1990;12:S92-8.
2. 2 Marshall BJ. Helicobacter pylori. Am J Gastroenterol 1994;89:5116-28.
3. 3 Stolte M, Eidt S. Helicobacter pylori and the evolution of gastritis. Scand J Gastroenterol 1996;(suppl 214):13-16.
4. 4 Robert ME, Weinstein WM, Helicobacter pylori-associated gastric pathology. Gastroenterol Clin North Am 1993;22:59-72.
5. 5 Fiocca R, Luinetti O, Villani L, et al. Epithelial cytotoxicity, immune responses, and inflammatory components of Helicobacter pylori gastritis. Scand J Gastroenterol 1994;(suppl 205):11-21.
6. 6 Wyatt JI, Rathbone BJ, Heatley RV. Local immune response to gastric Campylobacter in non-ulcer dyspepsia. J Clin Pathol 1986;39:863-70.
7. 7 Parsonnet J, Hansen S, Rodriguez L, et al. Helicobacter pylori infection and gastric lymphoma. N Engl J Med 1994;330:1267-71.
8. 8 Wotherspoon AC, Doglioni C, Diss TC, et al. Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet 1993;342:575-7.
9. 9 Telford JL, Covacci A, Rappuoli R, et al. Immunobiology of Helicobacter pylori infection. Curr Opin Immunol 1997;9:498-503.
10. 10 McGovern TW, Talley NJ, Kephart GM, et al. Eosinophil infiltration and degranulation in Helicobacter pylori-associated chronic gastritis. Dig Dis Sci 1991;36:435-40.
11. 11 Karttunen T, Niemela S, Lehtola J. Helicobacter pylori in dyspeptic patients; quantitative association with severity of gastritis, intragastric pH, and serum gastrin concentration. Scand J Gastroenterol 1991;(suppl 186):124-34.
12. 12 Niemela S, Karttunen T, Kerola T, et al. Ten year follow up study of lymphocytic gastritis: further evidence on Helicobacter pylori as a cause of lymphocytic gastritis and corpus gastritis. J Clin Pathol 1995;48:1111-16.
13. 13 Flejou JF, Bahamc P, Smith AC, et al. Pernicious anaemia and Campylobacter like organisms; is the gastric antrum resistant to colonisation? Gut 1989;30:60-4.
14. 14 Steer HW. The gastro-duodenal epithelium in peptic ulceration. J Pathol 1985;146:355-62.
15. + B cells are found in H. pylori-infected gastric mucosa. Am J Gastroenterol 1998;93:579-83.
16. 16 Stolte M, Eidt 5. Lymphoid follicles in antral mucosa: immune response to Campylobacter pylori? J Clin Pathol 1989;42:1269-71.
17. 17 Isaacson PG, Spencer J, Malignant lymphoma of mucosa-associated lymphoid tissue, Histopathology 1987;11:445-62.
18. 18 Mai UE, Perez-Perez GI, Wahl LM, et al. Soluble surface proteins from Helicobacter pylori activate monocytes/macrophages by lipopolysaccharide-independent mechanism. J Clin Invest 1991;87:894-900.
19. 19 Mui UE, Perez-Perez GI, Allen JB, et al. Surface proteins from Helicobacter pylori exhibit chemotactic activity for human leukocytes and are present in gastric mucosa. J Exp Med 1992;175:517-25.
20. 20 Huang J, O'Toole PW, Doig P, et al. Stimulation of interleukin-8 production in epithelial cell lines by Helicobacter pylori. Infect Immun 1995;63:1732-8.
21. 21 Sharma SA, Tummuru MK, Miller GG, at al. Interleukin-8 response of gastric epithelial cell lines to Helicobacter pylori stimulation in vitro. Inject Immun 1995;63:1681-7.
22. 22 Nielsen H, Andersen LP. Chemotactic activity of Helicobacter pylori sonicate for human polymorphonuclear leucocytes and monocytes. Gut 1992;33:738-42.
23. 23 Nielsen H, Andersen LP. Activation of human phagocyte oxidative metabolism by Helicobacter pylori. Gastroenterology 1992;103:1747-53.
24. 24 Blaser MJ. Hypotheses on the pathogenesis and natural history of Helicobacter pylori-induced inflammation. Gastroenterology 1992;102:720-7.
25. 25 Blaser MJ. Helicobacter pylori: microbiology of a 'slow' bacterial infection. Trends Microbiol 1993;7:255-60.
26. 26 Crabtree JE, Taylor JD, Wyatt JI, et al. Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology. Lancet 1991 10;338:332-5.
27. 27 Crabtree JE, Shallcross TM, Wyatt JI, et al. Mucosal humoral immune response to Helicobacter pylori in patients with duodenitis. Dig Dis Sci 1991;36:1266-73.
28. 28 Wyatt JI, Rathbone BJ. Immune response of the gastric mucosa to Campy lobacter pylori. Scand J Gastroenterol 1988;(suppl 142):44-9.
29. 29 Mollenkopf C, Steininger H, Weineck G, et al. Gastritis: immunohistochemical detection of specific and nonspecific immune response to Helicobacter pylori. Z Gastroenterol 1990;28:327-34.
30. 30 Luzza F, Maletta M, Irneneo M, et al. Salivary-specific immunoglobulin G in the diagnosis of Helicobacter pylori infection in dyspeptic patients. Am J Gastroenterol 1995;90:1820-3.
31. 31 Kosunen TU, Seppala K, Sarna S, et al. Diagnostic value of decreasing IgG, IgA, and IgM antibody titres after eradication of Helicobacter pylori. Lancet 1992;339:893-5.
32. 32 Hirschl AM, Brandstalter G, Dragosics B, et al. Kinetics of specific IgG antibodies for monitoring the effect of anti-Helicobacter pylori chemotherapy, J Infect Dis 1993,168:763-6.
33. 33 Bontkes HJ, Veenendaal RA, Pena AS, et al. IgG subclass response to Helicobacter pylori in patients with chronic active gastritis and duodenal ulcer. Scand J Gastroenterol 1992;27:129-33.
34. 34 Aceti A, Celestino D, Caferro M, et al. Basophil-bound and serum immunoglobulin E directed against Helicobacter pylori in patients with chronic gastritis. Gastroenterology 1991;101:131-7.
35. 35 Kleanthous H, Lee CK, Monath TP. Vaccine development against infection with Helicobacter pylori, Br Med Bull 1998;54:229-41.
36. 36 Thomas JE, Austin S, Dale A, et al. Protection by human milk IgA against Helicobacter pylori infection in infancy. Lancet 1993;342:121
37. 37 Watanabe T, Goto H, Arisawa T, et al. Relationship between local immune response to Helicobacter pylori and the diversity of disease: investigation of II. pylori-specific IgA in gasiric juice. J Gastroenterol Hepatol 1997;12:660-5.
38. 38 Bogstedt AK, Kava S, Wadstrom T, et al. Helicobacter pylori infections in IgA deficiency: lack of role for the secretory immune system. Clin Exp Immunol 1996;105:202-4.
39. 39 Schaffer FM, Monteiro RC, Volanakis JE, et al. IgA deficiency. Immunodefic Rev 1991;3:15-44.
40. 40 Tosi MF, Czinn SJ. Opsonic activity of specific human IgG against Helicobacter pylori. J Infect Dis. 1990;162:156-62.
41. 41 Cover TL, Cao P, Murthy UK, et al. Serum neutralizing antibody response to the vacuolating cytotoxin of Helicobacter pylori. J Clin Invest 1992;90:913-18.
42. 42 Sugiyama T, Awakawa T, Hayashi S, et al. The effect of the immune response to Helicobacter pylori in the development of intestinal metaplasia. Eur J Gastroenterol Hepatol 1994;6:S89-92.
43. 43 Negrini R, Lisato L, Zanella T, et al. Helicobacter pylori infection induces antibodies cross-reacting with human gastric mucosa. Gastroenterology 1991;101:437-45.
44. 44 Negrini R, Savin A, Poiesi C, et al. Antigenic mimicry between Helicobacter pylori and gastric mucosa in the pathogenesis of body atrophic gastritis. Gastroenterology 1996;111:655-65.
45. 45 Appelmelk BJ, Negrini R, Moran AP, et al. Molecular mimicry between Helicobacter pylori and the host. Trends Microbiol 1997;5:70-3.
46. 46 Appelmelk BJ, Simoons-Smit I, Negrini R, et al. Potential role of molecular mimicry between Helicobacter pylori lipopolysaccharide and host Lewis blood group antigens in autoimmunity. Infect Immun 1996;64:2031-40.
47. 47 Wirth HP, Yang M, Peek RM Jr, et al. Helicobacter pylori Lewis expression is related to the host Lewis phenotype. Gastroenterology 1997,113:1091-8.
48. 48 Appelmelk BJ, Faller G, Claeys D, et al. Bugs on trial: the case of Helicobacter pylori and autoimmunity, Immunol Today 1998;19:296-9.
49. 19 Desai HG, Amarapurkar DN. New look at chronic gastritis. J Clin Gastroenterol 1992;14:278-80.
50. 50 Suerbaum S, Thiberge JM, Kansau I, et al. Helicobacter pylori HspA-HspB heat-shock gene cluster: nucleotide sequence, expression, putative function and immunogenicity. Mol Microbiol 1994;14:959-74.
51. 51 Faulde M, Cremer J, Zoller L. Humoral immune response against Helicobacter pylori as determined by immunoblot. Electrophoresis 1993;14: 945-51.
52. 52 Aucher P, Petit ML, Mannant PR, et al. Use of immunoblot assay to define serum antibody patterns associated with Helicobacter pylori infection and with H. pylori-related ulcers. J Clin Microbiol 1998;36:931-6.
53. 53 Andersen LP, Espersen F. Immunoglobulin G antibodies to Helicobacter pylori in patients with dyspeptic symptoms investigated by the western immunoblot technique. J Clin Microbiol 1992;30:1743-51.
54. 54 Drouet EB, Denoyel GA, Boude M, et al. Characterization of an immunoreactive species-specific 19-kilodalton outer membrane protein from Helicobacter pylori by using a monoclonal antibody. J Clin Microbiol 1991;29:1620-4.
55. 55 Mattsson A, Quiding-Jarbrink M, Lonroth H, et al. Antibody-secreting cells in the stomachs of symptomatic and asymptomatic Helicobacter pylori-infected subjects. Infect Immun 1998;66:2705-12.
56. 56 Klaamas K, Held M, Wadstrom T, et al. IgG immune response to Helicobacter pylori antigens in patients with gastric cancer as defined by ELISA and immunoblotting. Int J Cancer 1996;67:1-5.
57. 57 Macchia G, Massonc A, Burroni D, at al. The Hsp60 protein of Helicobacter pylori: structure and immune response in patients with gastroduodenal diseases. Mol Microbiol 1993;9:645-52.
58. 58 Perez-Perez GI, Brown WR, Cover TL, et al. Correlation between scrological and mucosal inflammatory responses to Helicobacter pylori. Clin Diagn Lab Immunol 1994;1:325-9.
59. 59 Cover TL, Dooley CP, Blaser MJ. Characterization of and human serologic response to proteins in Helicobacter pylori broth culture supernatants with vacuolizing cytotoxin activity Infect Immun 1990;58:603-10.
60. 60 Covacci A, Censini S, Bugnoli M, et al. Molecular characterisation of the 128kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci USA 1993;90:5791-5.
61. 61 Graham DY, Genta RM, Graham DP, et al. Serum CagA antibodies in asymptomatic subjects and patients wiyh peptic ulcer: lack of correlation of IgG antibody in patients with peptic ulcer or asymptomatic Helicobacter pylori gastritis. J Clin Pathol 1996;49:829-32.
62. 62 Heikkinen M, Mayo K, Megraud F, et al. Association of CagA-positive and CagA-negative Helicobacter pylori strains with patients' symptoms and gastritis in primary care patients with functional upper abdominal complaints. Scand J Gastroenterol 1998;33:31-8.
63. 63 Parsonnet J, Friedman GD, Orentreich N, et al. Risk for gastric cancer in people with CagA positive or CagA negative Helicobacter pylori infection. Gut 1997;40:297-301.
64. 64 Ferrero RL, Thiberge JM, Hucrre M, et al. Recombinant antigens prepared from the urease subunits of Helicobacter spp.: evidence of protection in a mouse model of gastric infection. Infect Immun 1994;62:4981-9.
65. 65 Michetti F, Corthesy-Theulaz I, Davin C, et al. Immunization of BALB/c mice against Helicobacter felis infection with Helicobacter pylori urease. Gastroenterology 1994;107:1002-11.
66. 66 Lee CK, Weltzin R, Thomas WD Jr, et al. Oral immunisation with recombinant Helicobacter pylori urease induces secretory IgA antibodies and protects mice from challenge with Helicobacter felis. J Infect Dis 1995; 172:161-2.
67. 67 Cuenca R, Blanchard TG, Czinn SJ, et al. Therapeutic immunization against Helicobacter mustelac in naturally infected ferrets. Gastroenterology 1996;110:1770-5.
68. 68 Gomez-Duarte OG, Lucas B, Yan ZX, et al. Protection of mice against gastric colonization by Helicobacter pylori by single oral dose immunization with attenuated Salmonella tvphimurium producing urcase subunits A and B. Vaccine 1998;16:460-71.
69. 69 Marchetti M, Rossi M, Giannelli V, et al. Protection against Helicobacter pylori infection in mice by intragastric vaccination with H. pylori antigens is achieved using a non-toxic mutant of E. coli heat-labile enterotoxin (LT) as adjuvant. Vaccine 1998;16:33-7.
70. 70 Kleanthous H, Myers GA, Georgakopoulos KM, et al. Rectal and intranasal immunizations with recombinant urease induce distinct local and serum immune responses in mice and protect against Helicobacter pylori infection. Infect Immun 1998;66:2879-86.
71. 71 Ferrero RL, Thiberge JM, Kansau I, et al. The GroES homolog of Helicobacter pylori confers protective immunity against mucosal infection in mice. Proc Natl Acad Sci USA 1995;92:6499-503.
72. 72 Ghiara P, Rossi M, Marchetti M, et al. Therapeutic intrugastric vaccination against Helicobacter pylori in mice eradicates an otherwise chronic infection and confers protection against reinfection. Inject Immun 1997;65: 4996-5002.
73. 73 McAtee CP, Lim MY, Fung K, et al. Identification of potential diagnostic and vaccine candidates of Helicobacter pylori by two-dimensional gel electrophoresis, sequence analysis, and serum profiling. Clin Diagn Lab Immunol 1998;5:537-42.
74. 74 Hook-Kikanne J, Perez-Perez GI, Rlaser MJ. Antigenic characterisation of Helicobacter pylori strains from different parts of the world. Clin Diagn Lab Immunol 1997;4:592-7.
75. 75 Crabtree JE, Farmery SM, Helicobacter pylori and gastric mucosal cytokines: evidence that CagA-positive strains are more virulent. Lab Invest 1995;73:742-5.
76. 76 van Eden W, van der Zee R, Paul AG, et al. Do heat shock proteins control the balance of T-cell regulation in inflammatory diseases? Immunol Today 1998;19:303-7.
77. 77 Valnes K; Huitfeldt HS, Brandtzaeg P. Relation between T cell number and epithelial HLA class II expression quantified by image analysis in normal and inflamed human gastric mucosa. Gut 1990;31:647-52.
78. + but not gamma delta T-cells in the immune response to H. pylori antigens. Z Gastroenterol 1996;34:215-24.
79. 79 Engstrand L, Scheynius A, Pahlson C, et al. Association of Campylobacter pylori with induced expression of class II transplantation antigens on gastric epithelial cells. Infect Immun 1989;57:827-32.
80. 80 Papadimitriou CS, Ioachim-Velogianni EE, Tsianos EB, et al. Epithelial HLA-DR expression and lymphocyte subsets in gastric mucosa in type B chronic gastritis. Virchows Arch 1988;413:197-204.
81. + T cell activation during Helicobacter pylori infection. J Clin Invest 1997,99;1628-36.
82. 82 Harris PR, Mobley HL, Perez-Perez GI, et al. Helicobacter pylori urease is a potent stimulus of mononuclear phagocyte activation and inflammatory cytokine production. Gastroenterology 1996;111:419-25.
83. 83 Oberhuber G, Bodingbauer M, Mosberger I, et al. High proportion of granzyme B-positive (activated) intraepithelial and lamina propria lymphocytes in lymphocytic gastritis. Am J Surg Pathol 1998;22:150-8.
84. 84 Agnihotri N, Bhasin DK, Vohra H, et al. Characterisation of lymphocytic subsets and cytokine production in gastric biopsy samples from Helicobacter pylori patients. Scand J Gastroenterol 1998;33:704-9.
85. 85 Bamford KB, Fan X, Crowe SE, et al. Lymphocytes in the human gastric mucosa during Helicobacter pylori have a T helper cell 1 phenotype. Gastroenterology 1998;114:482-92.
86. 86 Hatz RA, Meimarakis G, Bayerdorffer E, et al. Characterization of lymphocytic infiltrates in Helicobacter pylori-associated gastritis. Scand J Gastroenterol 1996;31:222-8.
87. 87 Kayo MD, Whorwell PJ, Wright R. Gastric mucosal lymphocyte subpopulations in pernicious anemia and in normal stomach. Clin Immunol Immunopathol 1983;28:431-40.
88. 88 Carmel R, Bonne D, Parker JW. Lymphocyte surface phenotypes in pernicious anemia. Dig Dis Sci 1987;32:846-50.
89. 89 Trejdosiewicz LK, Calabrese A, Smart CJ, et al. Gamma delta T cell receptor-positive cells of the human gastrointestinal mucosa: occurrence and V region gene expression in Heliobacter pylori-associated gastritis, coeliac disease and inflammatory bowel disease. Clin Exp Immunol 1991;84:440-4.
90. 90 Fan XJ, Long A, Fan X, et al. Adhesion molecule expression on gastric intra-epithelial lymphocytes of patients with Helicohacter pylori infection. Eur J Gastroenterol Hepatol 1994;7:541-6.
91. 91 Kelleher D, Murphy A, Lynch S, et al. Adhesion molecules utilized in binding of intraepithelial lymphocytes to human enterocytes. Eur J Immunol 1994;24:1013-16.
92. 92 Fan XJ, Chua A, Shahi CN, et al. Gastric T lymphocyte responses to Helicobacter pylori in patients with H pylori colonisation. Gut 1994;35: 1379-84.
93. 93 Karttunen R. Blood lymphocyte proliferation, cytokine secretion and appearance of T cells with activation surface markers in cultures with Helicobacter pylori. Comparison of the responses of subjects with and without antibodies to H. pylori. Clin Exp Immunol 1991;83:396-400.
94. + T-cell clones from peripheral blood and gastric biopsies. Infect Immun 1995;63:1102-6.
95. 95 Karttunen R, Andersson G, Poikonen K, et al. Helicobacter pylori induces lymphocyte activation in peripheral blood cultures. Clin Exp Immunol 1990;82:485-8.
96. 96 Birkholz S, Knipp U, Opferkuch W. Stimulatory effects of Helicobacter pylori on human peripheral blood mononuclear cells of H. pylori infected patients and healthy blood donors. Zbl Bakt 1993;280:166-76.
97. 97 Hatz RA, Brooks WP, Andress H-J, et al. Specific suppression of the immune response of peripheral blood lymphocytes in Helicobacter pylori infection, Digestion 1991;49:18-9.
98. 98 Sharma SA, Miller GG, Perez-Perez GI, et al. Humoral and cellular immune recognition of Helicobacter pylori proteins are not concordant. Clin Exp Immunol 1994;97:126-32.
99. 99 Shahi CN, Fou XJ, Chua A, et al. Defective antigen-specific responses to Helicobacter pylori antigens in patients with gastric H. pylori colonisation. Ir J Med Sci 1992;161:54.
100. 100 Fan XG, Yakoob J, Fan XJ, et al. Enhanced T-helper 2 lymphocyte responses: Immune mechanism of Helicobacter pylori infection. Ir J Med Sci 1994;165:37-9.
101. 101 Duchmann R, Scherer H, Neurath M, et al. Normal interleukin-12 production in individuals with antibodies to Helicobacter pylori. APMIS 1997;105:824-30.
102. 102 Sharma SA, Miller GG, Peek RA Jr, et al. T-cell, antibody, and cytokine responses to homologs of the 60-kilodalton heat shock protein in Helicobacter pylori infection. Clin Diagn Lab Immunol 1997;4:440-6.
103. 103 D'Elios MM, Manghetti M, De Carli M, et al. T helper 1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease. J Immunol 1997;158:962-7.
104. 104 D'Elios MM, Manghetti M, Almerigogna F, et al. Different cytokine profile and antigen-specificity repertoire in Helicobacter pylori-specific T cell clones from the antrum of chronic gastritis patients with or without peptic ulcer. Eur J Immunol 1997;27:1751-5.
105. 105 Good MF, Zevering Y, Currier J, et al. 'Original antigenic sin', T cell memory, and malaria sporozoite immunity: an hypothesis for immune evasion. Parasite Immunol 1993;15:187-93.
106. 106 Zevering Y, Amante F, Smillie A, et al. High frequency of malaria-specific T cells in non-exposed humans, Eur J Immunol 1992;22:689-96.
107. 4 malaria-specific responses from non-exposed donors. Int Immunol 1992;4:985-94.
108. 108 Zevering Y, Khamboonruang C, Good MF. Human and murine T-cell responses to allelic forms of a malaria circumsporozoite protein epitope support a polyvalent vaccine strategy. Immunology 1998;94:445-54.
109. 109 Klenerman P, Zinkernagel RM. Original antigenic sin impairs cytotoxic T lymphocyte responses to viruses bearing variant epitopes. Nature 1998;394: 482-5.
110. 110 Ihan A, Tepez B, Kavcic I, et al. IL-2 receptor expression on gastric mucosa T lymphocytes is enhanced in duodenal ulcer patients compared with non-ulcer dyspeptic patients, Hepatogastroenterology 1996;43:1665-70.
111. 111 Koulis A, Diss T, Isaacson PG, et al. Characterization of tumor-infiltrating T lymphocytes in B-cell lymphomas of mucosa-associated lymphoid tissue. Am J Pathol 1997;151:1353-60.
112. 112 Hussell T, Isaacson PG, Crabtree JE, et al. The response of cells from low-grade B-cell gastric lymphomas of mucosa-associated lymphoid tissue to Helicobacter pylori. Lancet 19934;342:571-4.
113. 113 Hussell T, Isaacson PG, Crabtree JE, et al. Helicobacter pylori-specific tumour-infiltrating T cells provide contact dependent help for the growth of malignant B cells in low-grade gastric lymphoma of mucosa-associated lymphoid tissue. J Pathol 1996;178:122-7.
114. 114 Greiner A, Knorr C, Qin Y, et al. Low-grade B cell lymphomas of mucosa-associated lymphoid tissue (MALT-type) require CD40-mediated signaling and Th2-type cytokines for in vitro growth and differentiation. Am J Pathol 1997;150:1583-93.
115. 115 Romagnani S. Th1 and Th2 in human diseases. Clin Immunol Immunopathol 1996;80:225-35.
116. 116 Mosmann TR, Sad S, The expanding universe of T-cell subsets: Th1, Th2 and more, Immunol Today 1996;17:138-46.
117. 117 Nielsen H, Andersen LP. Activation of phagocytes by Helicobacter pylori correlates with the clinical presentation of the gastric infection. Scand J Infect Dis 1995;27:347-50.
118. 118 Wagner S, Beil W, Westermann J, et al. Regulation of gastric epithelial cell growth by Helicobacter pylori: evidence for a major role of apoptosis. Gastroenterology 1997;113:1836-47.
119. 119 Wilson KT, Ramanujam KS, Mobley HL, et al. Helicobacter pylori stimulates inducible nitric oxide synthase expression and activity in a murine macrophage cell line. Gastroenterology 1996;111:1524-33.
120. 120 Mooney C, Keenan J, Munster D, et al. Keutrophil activation by Helicobacter pylori. Gut 1991;32:853-7.
121. 1 Helicobacter pylori strains. Lab Invest 1995;73:760-70.
122. 122 Haeberle HA, Kubin M, Bamford KB, et al. Differential stimulation of interleukin-12 (IL-12) and IL-10 by live and killed Helicobacter pylori in vitro and association of IL-12 production with gamma interferon-producing T cells in the human gastric mucosa. Infect Immun 1997;65: 4229-35.
123. 123 Yamaoka Y, Kita M, Kodama T, et a/. Expression of cytokine mRNA in gastric mucosa with Helicobacter pylori infection. Scand J Gastroenterol 1995;30:1153-9.
124. 124 Karttunen R, Karttunen T, Ekre HP, et al. Interferon gamma and interleukin 4 secreting cells in the gastric antrum in Helicobacter pylori positive and negative gastritis. Gut 1995;36:341-5.
125. 125 Karttunen RA, Karttunen TJ, Yousfi MM, et al. Expression of mRNA for interferon-gamma, interleukin-10, and interleukin-12 (p40) in normal gastric mucosa and in mucosa infected with Helicobacter pylori. Scand J Gastroenterol 1997;32:22-7.
126. 126 Sommer F, Faller G, Konturek P, et al. Antrum-and corpus mucosa-infiltrating CD4(+) lymphocytes in Helicobacter pylori gastritis display a Th1 phenotype. Infect Immun 1998;66:5543-6.
127. 127 Lindholm C, Quiding-Jarbrink M, Lonroth H, et al. Local cytokine response in Helicobacter pylori-infected subjects. Infect Immun 1988;66: 5964-71.
128. 128 Bodger K, Wyatt JI, Heatley RV. Gastric mucosal secretion of interleukin-10: Relations to histopathology, Helicobacter pylori status, and tumour necrosis factor-alpha secretion. Gut 1997;40:739-44.
129. 129 Chakrabarti D, Hultgren B, Stewart TA. IFN-alpha induces autoimmune T cells through the induction of intracellular adhesion molecule-1 and B7.2. J Immunol 1996,157:522-8.
130. 130 Aderka D, Le JM, Vilcek J. IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice. J Immunol 1989;143:3517-23.
131. 131 Crabtree JE, Shallcross TM, Heatley RV, et al. Mucosal tumour necrosis factor alpha and interleukin-6 in patients with Helicobacter pylori associated gastritis. Gut 1991;32:1473-7.
132. 132 Letterio JJ, Roberts AB. Regulation of immune responses by TGF-beta. Annu Rev Immunol 1998;16:137-61.
133. 133 Hamann D, Hilkens CM, Grogan JL, et al. CD30 expression does not discriminate between human Th1-and Th2-type T cells. J Immunol 1996;156:1387-91.
134. 134 Barnard A, Mahon BP, Watkins J, et al. Th1/Th2 cell dichotomy in acquired immunity to Bordetella pertussis: variables in the in vivo priming and in vitro cytokine detection techniques affect the classification of T-cell subsets as Th1, Th2 or Th0. Immunology 1996;87:372-80.
135. 135 Saldinger PF, Porta N, Launois P, et al. Immunization of BALB/c mice with Helicobacter urease B induces a T helper 2 response absent in Helicobacter infection. Gastroenterology 1998;115:891-7.
136. 136 Guy B, Hessler C, Fourage S, et al. Systemic immunization with urease protects mice against Helicobacter pylori infection. Vaccine 1998;16:850-6.
137. 137 Fratazzi C, Guerriero M, Carini C. Interleukin 7 and sCD23 synergize in the induction of human T cell activation in HIV-1-infected subjects, Int Arch Allergy Immunol 1997;114:120-9.
138. 138 Mchrotra PT, Grant AJ, Siegel JP. Synergistic effects of IL-7 and IL-12 on human T cell activation. J Immunol 1995;154:5093-102.
139. 139 Gessner A, Will A, Victh M, et al. Stimulation of B-cell lymphopoiesis by interleukin-7 leads to aggravation of murine leishmaniasis. Immunology 1995;84:416-22.
140. 140 Leong KH, Ramshaw IA, Ramsay AJ. Interleukin-7 enhances cell-mediated immune responses in vivo in an interleukin-2-dependent manner. Viral Immunol 1997;10:1-9.
141. 141 Carini C, Essex M. Interleukin 2-independent interleukin 7 activity enhances cytotoxic immune response of HIV-1-infected individuals. AIDS Res Hum Retroviruses 1994;10:121-30.
142. 142 Michetti P. Vaccine against Helicobacter pylori: fact or fiction. Gut 1997;41:728-30.
143. 143 Blaser MJ. Helicobacter pylori and gastric diseases. BMJ 1998;316:1507-10.
144. 144 Labenz J, Blum AL, Bayerdorffer E, et al. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis. Gastroenterology 1997;112:1442-7.
145. 145 Schutze K, Hentschel E, Dragosics B, et al. Helicobacter pylori reinfection with identical organisms: transmission by the patients' spouses. Gut 1995; 36:831-3.
146. + strains of Helicobacter pylori infection and risk of esophageal and gastric cardia adenocarcinoma. Cancer Res 1998;58:588-90.